inHEART
inHEART develops AI-enabled digital twin software that converts cardiac CT and MR images into interactive 3D models for image-guided ablation procedures, sold to cardiac electrophysiology centers in over 40 countries.
- Company typePrivate
- Founded2017
- HeadquartersPessac, France
- Headcount11–50
- GTM typeB2B
- OfferingSoftware
What inHEART does
inHEART is a privately-held French medical device software company, spun off in July 2017 from IHU LIRYC (a leading cardiac electrophysiology research institute in Bordeaux), that develops an AI-enabled digital twin of the human heart for image-guided catheter ablation procedures. The company's flagship inHEART MODELS software suite ingests pre-procedural CT and MR images, applies a proprietary AI segmentation algorithm, and produces interactive 3D cardiac models that visualize scar tissue, wall thickness, and critical isthmuses, then integrates with all major electroanatomic mapping systems (Carto, Rhythmia, EnSite) for intraprocedural guidance. The technology is clinically validated by 60+ peer-reviewed publications, FDA 510(k) cleared (including a March 2024 clearance for first-of-its-kind fully automated CT segmentation), CE certified under MDR 2017/745, and registered in the UK, Australia, and Switzerland.
The commercial model is enterprise SaaS-style software licensing sold directly to tertiary and quaternary cardiac electrophysiology centers, with a quote-based pricing structure and recurring subscription mechanics. Cumulative case support exceeds 7,500 across more than 300 partner hospitals in over 40 countries, with named reference sites including MUSC Health, RHÖN KLINIKUM, Brigham and Women's, Hartford Healthcare, Hôpitaux de la Timone, and Nippon Medical School. Distribution is hybrid: direct sales in the US and EU, regional distributors (Medical Horizons in Italy), and a May 2024 global distribution agreement with Circle Cardiovascular Imaging that is the primary vehicle for Asia-Pacific and Middle East expansion.
The business is funded by approximately $15.7M in equity and grant funding across seed, Series A, and follow-on rounds, with Vesalius Biocapital IV and Elaia Partners as lead institutional investors. Revenue is not publicly disclosed. Current strategic priorities include scaling the commercial core, building predictive AI product lines for sudden cardiac death, cardioembolic stroke, and heart failure (supported by the MEDITWIN and TALENT consortia), and pursuing global regulatory clearance to enable channel-driven geographic expansion beyond the existing US and EU footprint.
inHEART firmographics
Firmographics- Name
- inHEART
- Legal name
- inHEART
- Website
- https://inheartmedical.com
- Company type
- Private
- Founded year
- 2017
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- inHEART develops AI-enabled digital twin software that converts cardiac CT and MR images into interactive 3D models for image-guided ablation procedures, sold to cardiac electrophysiology centers in over 40 countries.
- Ownership category
- akta.pro rank
inHEART industry classification
Industry- Product category
- Cardiac Electrophysiology Software
- NAICS
- Electromedical and Electrotherapeutic Apparatus Manufacturing (334510), Computer Systems Design and Related Services (54151), Diagnostic Imaging Centers (621512)
- SIC
- Surgical & Medical Instruments & Apparatus (3841), Services-Health Services (8000), Services-Computer Integrated Systems Design (7373)
- akta.pro primary industry
- Electrophysiology (Heart Rhythm) (HLAKABAC)
- akta.pro secondary industry
- Radiology AI, CAD & Advanced Visualization Software (HLAHABAJ)
Keywords
Where inHEART is headquartered
LocationHeadquarters
- HQ city
- Pessac
- HQ country
- France
- HQ region
- Europe
Offices2 records
Markets served
inHEART business model
Business model- GTM type
- B2B
- Offering type
- Software
- Cost components
- Personnel, Technology or R&D, Operations, Marketing or Sales, Infrastructure
Revenue model
- Software Licensing - Therapeutic Solutions: AI-driven digital twin software for image-guided cardiac ablation procedures, sold to hospitals and cardiac electrophysiology centers. Revenue derived from software licenses for the inHEART MODELS suite enabling 3D visualization and analysis for pre-procedural planning and intraprocedural guidance.
- Predictive Software Models (Development Stage): New product verticals under development for AI-driven predictive software models for sudden cardiac death and cardio-embolic stroke, as well as therapeutic software for heart failure patients.
Go-to-market motion2 records
Distribution channels4 records
Marketing channels7 records
inHEART product offering
Product offeringCore offering
inHEART provides a cloud-based SaaS platform, inHEART MODELS, that uses proprietary AI segmentation algorithms to transform cardiac CT and MR images into interactive 3D digital twin models for pre-procedural planning and intraprocedural guidance of catheter ablation procedures treating arrhythmias such as ventricular tachycardia (VT), atrial fibrillation (AF), and cardioneuroablation. The software integrates with all major electroanatomic mapping (EAM) systems (Carto, Rhythmia, EnSite) and is licensed to hospitals and cardiac electrophysiology centers under a subscription-based model.
Product overview
inHEART delivers the world's most advanced AI-enabled digital twin of the heart through a cloud-based SaaS platform. The core offering is the inHEART MODELS software suite that creates interactive 3D models from CT and MR images for image-guided cardiac ablation planning. The platform includes AI-driven automated segmentation capabilities and integrates with all major electroanatomic mapping (EAM) systems. Current commercial products include therapeutic solutions for VT ablation, atrial fibrillation, and cardioneural ablation. Development underway includes predictive models for sudden cardiac death, cardio-embolic stroke, and heart failure. The company operates through the MEDITWIN and TALENT consortia for preventive cardiac care solutions. Available in US (FDA 510(k) cleared) and EU (CE MDR certified) markets.
Differentiator
Problem solved
Functional benefit
Products and services
- inHEART MODELS (Digital Twin of the Heart) AI-enabled cloud-based software suite that creates interactive 3D digital twin models of the heart from CT and MR images, providing unprecedented anatomical detail including scar visualization, wall thickness, tissue characteristics, and critical isthmus identification for personalized image-guided cardiac ablation planning. Licensed to hospitals and cardiac electrophysiology centers on a subscription basis and integrates with all major electroanatomic mapping (EAM) systems including Carto, Rhythmia, and EnSite.
Quantifiable outcome
- Reduces procedure time by 60% (from 5 hours to less than 2 hours)
- +2 more outcomes
Companies that use inHEART
Customer profileNamed customers10 records
Segments2 records
Ideal customer profiles2 records
inHEART technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
AI capability6 records
Feature7 records
inHEART partnerships and signals
Strategic signalPartnerships
Six partnerships are on record, tiered core, regional and minor.
- Circle Cardiovascular ImagingcoreGlobal distribution agreement enabling Circle to promote and market inHEART's AI-enabled digital twin through Circle's worldwide sales network. Partnership enables rapid global commercialization and particularly strengthens Asia-Pacific market presence.
- Dassault Systèmes (MEDITWIN Consortium)coreMEDITWIN is a 5-year multidisciplinary consortium (2024-2029) evaluating personalized digital twins in healthcare. inHEART focuses on sudden cardiac death prevention using AI-based digital twin technology for risk stratification. Supported by French government.
- IHU LiryccoreinHEART is a spin-off company of IHU Liryc, the cardiac electrophysiology institute. Long-standing research and development partnership for cardiac imaging innovation.
- TALENT ConsortiumcoreCollaboration with 9 academic, hospital, and industrial partners to screen for Cardioembolic Stroke risk using AI-based digital twins via chest CT and ECG. Supported by French government under France 2030 program.
- Medical HorizonsregionalPartnership with Medical Horizons S.r.l to deliver inHEART 3D cardiac modeling software solution to heart centers across Italy. Guido Osti, CEO of Medical Horizons, leads commercialization efforts.
- CHU de BordeauxminorAcademic hospital partner in France for clinical research and development.
Scale indicators11 records
Recent moves8 records
Expansion highlights6 records
inHEART competitors and assessment
Company assessmentDirect peers
- Galgo Medical (ADAS 3D): Spanish company offering ADAS 3D software for cardiac image-guided procedures including VT and AF ablation planning. Closest direct competitor to inHEART MODELS with similar pre-procedural 3D modeling, scar characterization and EAM integration approach.
- Circle Cardiovascular Imaging: Canadian cardiac MR/CT imaging software company that is both inHEART's global distribution partner and a competitor in the cardiac imaging analysis space. Offers cvi42 for cardiac MR/CT which overlaps with parts of inHEART's analytical workflow.
Broad incumbents
- Philips (Cardiologs): Global medtech incumbent with cardiac imaging portfolio and AI ECG interpretation via Cardiologs acquisition. Operates broadly across the cardiac care continuum and has both the imaging and AI capabilities that compete with inHEART's therapeutic and predictive roadmap.
- Siemens Healthineers: Major medical imaging vendor with cardiac CT/MR portfolio and growing AI imaging capabilities. CTO Loïc Cadour's prior work on cross-platform image processing at INRIA was closely tied to cardiac imaging research with Siemens, and Siemens represents both a complementary imaging ecosystem and a competitive threat.
- GE HealthCare: Cardiac ultrasound and imaging incumbent that previously employed CEO Todor Jeliaskov (VP at GE Ultrasound). Has scale and distribution capabilities that dwarf inHEART and could choose to enter pre-procedural cardiac modeling natively.
- Biosense Webster (Johnson & Johnson): Market-leading electrophysiology company behind the Carto 3 EAM system, which inHEART MODELS integrates with. Acquired Jeliaskov's prior company NuVera Medical. Could trivially bundle a competing pre-procedural imaging module.
- Abbott: Medical device incumbent offering the EnSite X EAM system that integrates with inHEART. Employs several of inHEART's sales staff (Richard Bloch, Charlotte Pollmann) per previous employer history and has resources to develop competing AI imaging.
- Boston Scientific: EP and cardiac device incumbent behind the Rhythmia HDx mapping system that inHEART integrates with. Acquired Cardiac Pathways, where consultant Dave Robinson previously worked, and has the scale to develop or acquire pre-procedural imaging capability.
Emerging players
- Tempus AI (Arterys): AI-driven precision medicine company that acquired Arterys, the cardiac MR AI imaging pioneer. Provides cloud-based cardiac MR analysis with deep-learning segmentation that overlaps with parts of inHEART's automated segmentation value proposition.
- Viz.ai: AI-driven care coordination and imaging analytics company that has expanded from stroke into cardiology. While focused on acute care coordination rather than procedural planning, it shares the AI-imaging-in-clinical-workflows DNA and similar hospital SaaS commercial model.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat6 records
Key risks6 records
Key highlights7 records
Customer concentration
inHEART social profiles
Digital presenceinHEART compliance and trust
Trust signalCompliance8 records
inHEART financial estimates
Financial estimateRevenue estimate
Valuation estimate
inHEART leadership team
Management profileNumber of profiles
Profiles11 records
inHEART subsidiaries and ownership
Company hierarchySubsidiaries1 record
inHEART funding detail
Funding detailFunding overview
Funding rounds3 records
Investors9 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
inHEART M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about inHEART
What does inHEART do?
inHEART provides a cloud-based SaaS platform, inHEART MODELS, that uses proprietary AI segmentation algorithms to transform cardiac CT and MR images into interactive 3D digital twin models for pre-procedural planning and intraprocedural guidance of catheter ablation procedures treating arrhythmias such as ventricular tachycardia (VT), atrial fibrillation (AF), and cardioneuroablation. The software integrates with all major electroanatomic mapping (EAM) systems (Carto, Rhythmia, EnSite) and is licensed to hospitals and cardiac electrophysiology centers under a subscription-based model.
Is inHEART a public or private company?
inHEART is a private company. It is classified as venture growth investor backed and is currently operating.
When was inHEART founded?
inHEART was founded in 2017. It employs 11 to 50 people.
Where is inHEART based?
inHEART is headquartered in Pessac, France, in the Europe region.
How does inHEART make money?
Two revenue lines are on record. Software Licensing - Therapeutic Solutions are the primary driver. The others are predictive Software Models (Development Stage).
Who are inHEART's main competitors?
Direct peers on record are Galgo Medical (ADAS 3D) and Circle Cardiovascular Imaging. Broad incumbents are Philips (Cardiologs), Siemens Healthineers, GE HealthCare, Biosense Webster (Johnson & Johnson), Abbott and Boston Scientific. Emerging players are Tempus AI (Arterys) and Viz.ai.
Does inHEART have an API?
No public API is recorded for inHEART.
What industry is inHEART in?
inHEART's product category is Cardiac Electrophysiology Software. Its primary akta.pro industry code is HLAKABAC, Electrophysiology (Heart Rhythm), with a secondary code of HLAHABAJ, Radiology AI, CAD & Advanced Visualization Software. Its NAICS code is 334510 and its SIC code is 3841.